nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Pemetrexed—lung cancer	0.704	0.855	CbGbCtD
Trimetrexate—DHFR—Methotrexate—lung cancer	0.12	0.145	CbGbCtD
Trimetrexate—DHFR—Nucleotide Metabolism—RRM1—lung cancer	0.00373	0.0705	CbGpPWpGaD
Trimetrexate—Trimethoprim—TYMS—lung cancer	0.00255	0.798	CrCbGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—RRM1—lung cancer	0.0024	0.0453	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—ABCC3—lung cancer	0.00204	0.0386	CbGpPWpGaD
Trimetrexate—DHFR—G1/S-Specific Transcription—TYMS—lung cancer	0.00173	0.0327	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—ABCG2—lung cancer	0.00166	0.0314	CbGpPWpGaD
Trimetrexate—DHFR—E2F mediated regulation of DNA replication—PPP2R1B—lung cancer	0.00162	0.0306	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—GCLC—lung cancer	0.0016	0.0303	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—CYP2A6—lung cancer	0.00156	0.0296	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—HMGB2—lung cancer	0.00146	0.0276	CbGpPWpGaD
Trimetrexate—Alanine aminotransferase increased—Crizotinib—lung cancer	0.00136	0.0118	CcSEcCtD
Trimetrexate—Serum creatinine increased—Irinotecan—lung cancer	0.00133	0.0116	CcSEcCtD
Trimetrexate—Blood creatinine increased—Pemetrexed—lung cancer	0.00132	0.0114	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—SMUG1—lung cancer	0.00127	0.0241	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—RRM1—lung cancer	0.00127	0.024	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—MCL1—lung cancer	0.00127	0.024	CbGpPWpGaD
Trimetrexate—Aspartate aminotransferase increased—Pemetrexed—lung cancer	0.00127	0.011	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Gefitinib—lung cancer	0.00126	0.0109	CcSEcCtD
Trimetrexate—Neutropenia—Crizotinib—lung cancer	0.00124	0.0108	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Pemetrexed—lung cancer	0.00124	0.0107	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Gefitinib—lung cancer	0.00123	0.0107	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Topotecan—lung cancer	0.00123	0.0107	CcSEcCtD
Trimetrexate—Serum creatinine increased—Cisplatin—lung cancer	0.00121	0.0105	CcSEcCtD
Trimetrexate—DHFR—One Carbon Metabolism—TYMS—lung cancer	0.00116	0.022	CbGpPWpGaD
Trimetrexate—Neutropenia—Pemetrexed—lung cancer	0.00114	0.00985	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RRM1—lung cancer	0.00111	0.0209	CbGpPWpGaD
Trimetrexate—Blood bilirubin increased—Vinorelbine—lung cancer	0.00105	0.00912	CcSEcCtD
Trimetrexate—DHFR—respiratory system—lung cancer	0.00105	0.211	CbGeAlD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—lung cancer	0.00105	0.0197	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—XRCC1—lung cancer	0.00104	0.0196	CbGpPWpGaD
Trimetrexate—Hepatotoxicity—Gemcitabine—lung cancer	0.00104	0.00897	CcSEcCtD
Trimetrexate—DHFR—E2F mediated regulation of DNA replication—TYMS—lung cancer	0.00102	0.0193	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—TYMS—lung cancer	0.00102	0.0193	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MSH6—lung cancer	0.000985	0.0186	CbGpPWpGaD
Trimetrexate—Hepatotoxicity—Cisplatin—lung cancer	0.000965	0.00836	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—ERCC2—lung cancer	0.000948	0.0179	CbGpPWpGaD
Trimetrexate—Neutropenia—Teniposide—lung cancer	0.000921	0.00798	CcSEcCtD
Trimetrexate—Hepatotoxicity—Etoposide—lung cancer	0.000884	0.00766	CcSEcCtD
Trimetrexate—Hypocalcaemia—Gemcitabine—lung cancer	0.000873	0.00757	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Irinotecan—lung cancer	0.000868	0.00752	CcSEcCtD
Trimetrexate—DHFR—bronchus—lung cancer	0.000862	0.174	CbGeAlD
Trimetrexate—Anaemia—Crizotinib—lung cancer	0.000857	0.00742	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Gemcitabine—lung cancer	0.000845	0.00732	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Irinotecan—lung cancer	0.000821	0.00711	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Gemcitabine—lung cancer	0.000799	0.00693	CcSEcCtD
Trimetrexate—Anaemia—Pemetrexed—lung cancer	0.000783	0.00678	CcSEcCtD
Trimetrexate—Anaemia—Gefitinib—lung cancer	0.000778	0.00674	CcSEcCtD
Trimetrexate—DHFR—trachea—lung cancer	0.000774	0.156	CbGeAlD
Trimetrexate—Aspartate aminotransferase increased—Topotecan—lung cancer	0.00076	0.00659	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Topotecan—lung cancer	0.000745	0.00645	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Erlotinib—lung cancer	0.000737	0.00638	CcSEcCtD
Trimetrexate—Hepatotoxicity—Docetaxel—lung cancer	0.000735	0.00637	CcSEcCtD
Trimetrexate—Hypocalcaemia—Paclitaxel—lung cancer	0.000731	0.00634	CcSEcCtD
Trimetrexate—DHFR—cardiac atrium—lung cancer	0.000727	0.147	CbGeAlD
Trimetrexate—Hyponatraemia—Vinorelbine—lung cancer	0.000725	0.00628	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Paclitaxel—lung cancer	0.000708	0.00613	CcSEcCtD
Trimetrexate—DHFR—E2F mediated regulation of DNA replication—RB1—lung cancer	0.000691	0.0131	CbGpPWpGaD
Trimetrexate—Blood alkaline phosphatase increased—Irinotecan—lung cancer	0.000685	0.00593	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Etoposide—lung cancer	0.000683	0.00592	CcSEcCtD
Trimetrexate—Neutropenia—Topotecan—lung cancer	0.000682	0.00591	CcSEcCtD
Trimetrexate—Thrombocytopenia—Pemetrexed—lung cancer	0.000677	0.00586	CcSEcCtD
Trimetrexate—Blood creatinine increased—Vinorelbine—lung cancer	0.000677	0.00586	CcSEcCtD
Trimetrexate—Neutropenia—Erlotinib—lung cancer	0.000675	0.00585	CcSEcCtD
Trimetrexate—Thrombocytopenia—Gefitinib—lung cancer	0.000672	0.00583	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Paclitaxel—lung cancer	0.000669	0.0058	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Gemcitabine—lung cancer	0.000667	0.00578	CcSEcCtD
Trimetrexate—Fatigue—Crizotinib—lung cancer	0.000652	0.00565	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Vinorelbine—lung cancer	0.00065	0.00564	CcSEcCtD
Trimetrexate—Trimethoprim—ABCB1—lung cancer	0.000645	0.202	CrCbGaD
Trimetrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—lung cancer	0.000641	0.0121	CbGpPWpGaD
Trimetrexate—Anaemia—Teniposide—lung cancer	0.000634	0.00549	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—PPP2R1B—lung cancer	0.000623	0.0118	CbGpPWpGaD
Trimetrexate—DHFR—bone marrow—lung cancer	0.000614	0.124	CbGeAlD
Trimetrexate—DHFR—Folate Metabolism—CAT—lung cancer	0.000613	0.0116	CbGpPWpGaD
Trimetrexate—Blood bilirubin increased—Docetaxel—lung cancer	0.0006	0.0052	CcSEcCtD
Trimetrexate—Hyponatraemia—Irinotecan—lung cancer	0.000598	0.00518	CcSEcCtD
Trimetrexate—Body temperature increased—Crizotinib—lung cancer	0.000598	0.00518	CcSEcCtD
Trimetrexate—Fatigue—Pemetrexed—lung cancer	0.000596	0.00516	CcSEcCtD
Trimetrexate—Fatigue—Gefitinib—lung cancer	0.000592	0.00513	CcSEcCtD
Trimetrexate—Neutropenia—Vinorelbine—lung cancer	0.000584	0.00506	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—SOD2—lung cancer	0.000581	0.011	CbGpPWpGaD
Trimetrexate—Serum creatinine increased—Doxorubicin—lung cancer	0.000576	0.00499	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Etoposide—lung cancer	0.00057	0.00494	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Docetaxel—lung cancer	0.000567	0.00492	CcSEcCtD
Trimetrexate—Confusional state—Teniposide—lung cancer	0.000565	0.00489	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Paclitaxel—lung cancer	0.000559	0.00484	CcSEcCtD
Trimetrexate—Blood creatinine increased—Irinotecan—lung cancer	0.000558	0.00484	CcSEcCtD
Trimetrexate—DHFR—lung—lung cancer	0.000556	0.112	CbGeAlD
Trimetrexate—Thrombocytopenia—Teniposide—lung cancer	0.000548	0.00475	CcSEcCtD
Trimetrexate—Body temperature increased—Pemetrexed—lung cancer	0.000546	0.00474	CcSEcCtD
Trimetrexate—Blood creatinine increased—Gemcitabine—lung cancer	0.000544	0.00471	CcSEcCtD
Trimetrexate—Hyponatraemia—Cisplatin—lung cancer	0.000543	0.00471	CcSEcCtD
Trimetrexate—Body temperature increased—Gefitinib—lung cancer	0.000543	0.00471	CcSEcCtD
Trimetrexate—Asthenia—Crizotinib—lung cancer	0.000543	0.0047	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—TYMS—lung cancer	0.00054	0.0102	CbGpPWpGaD
Trimetrexate—Aspartate aminotransferase increased—Irinotecan—lung cancer	0.000536	0.00465	CcSEcCtD
Trimetrexate—Hepatotoxicity—Methotrexate—lung cancer	0.000529	0.00459	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—PPP2R1B—lung cancer	0.000525	0.00992	CbGpPWpGaD
Trimetrexate—Aspartate aminotransferase increased—Gemcitabine—lung cancer	0.000522	0.00453	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Gemcitabine—lung cancer	0.000512	0.00443	CcSEcCtD
Trimetrexate—Blood creatinine increased—Cisplatin—lung cancer	0.000507	0.00439	CcSEcCtD
Trimetrexate—Asthenia—Pemetrexed—lung cancer	0.000496	0.0043	CcSEcCtD
Trimetrexate—Asthenia—Gefitinib—lung cancer	0.000493	0.00427	CcSEcCtD
Trimetrexate—Pruritus—Pemetrexed—lung cancer	0.000489	0.00424	CcSEcCtD
Trimetrexate—Hyponatraemia—Paclitaxel—lung cancer	0.000488	0.00423	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Cisplatin—lung cancer	0.000487	0.00422	CcSEcCtD
Trimetrexate—Pruritus—Gefitinib—lung cancer	0.000486	0.00421	CcSEcCtD
Trimetrexate—Anaemia—Vinblastine—lung cancer	0.000484	0.00419	CcSEcCtD
Trimetrexate—Neutropenia—Irinotecan—lung cancer	0.000481	0.00417	CcSEcCtD
Trimetrexate—Vomiting—Crizotinib—lung cancer	0.000481	0.00417	CcSEcCtD
Trimetrexate—Rash—Crizotinib—lung cancer	0.000477	0.00413	CcSEcCtD
Trimetrexate—Dermatitis—Crizotinib—lung cancer	0.000476	0.00413	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Docetaxel—lung cancer	0.000473	0.0041	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—APOA1—lung cancer	0.000471	0.0089	CbGpPWpGaD
Trimetrexate—Anaemia—Topotecan—lung cancer	0.00047	0.00407	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TYMS—lung cancer	0.000469	0.00887	CbGpPWpGaD
Trimetrexate—Neutropenia—Gemcitabine—lung cancer	0.000469	0.00406	CcSEcCtD
Trimetrexate—Feeling abnormal—Teniposide—lung cancer	0.000461	0.004	CcSEcCtD
Trimetrexate—Blood creatinine increased—Paclitaxel—lung cancer	0.000455	0.00394	CcSEcCtD
Trimetrexate—Convulsion—Vinblastine—lung cancer	0.000453	0.00393	CcSEcCtD
Trimetrexate—Nausea—Crizotinib—lung cancer	0.000449	0.00389	CcSEcCtD
Trimetrexate—DHFR—Metabolism of nitric oxide—AKT1—lung cancer	0.000444	0.00839	CbGpPWpGaD
Trimetrexate—Body temperature increased—Teniposide—lung cancer	0.000443	0.00384	CcSEcCtD
Trimetrexate—Vomiting—Pemetrexed—lung cancer	0.000439	0.00381	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Paclitaxel—lung cancer	0.000437	0.00379	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Etoposide—lung cancer	0.000437	0.00379	CcSEcCtD
Trimetrexate—Vomiting—Gefitinib—lung cancer	0.000437	0.00378	CcSEcCtD
Trimetrexate—Rash—Pemetrexed—lung cancer	0.000436	0.00378	CcSEcCtD
Trimetrexate—Dermatitis—Pemetrexed—lung cancer	0.000435	0.00377	CcSEcCtD
Trimetrexate—Rash—Gefitinib—lung cancer	0.000433	0.00375	CcSEcCtD
Trimetrexate—Dermatitis—Gefitinib—lung cancer	0.000433	0.00375	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Paclitaxel—lung cancer	0.000428	0.00371	CcSEcCtD
Trimetrexate—Thrombocytopenia—Vinblastine—lung cancer	0.000418	0.00362	CcSEcCtD
Trimetrexate—Hyponatraemia—Docetaxel—lung cancer	0.000413	0.00358	CcSEcCtD
Trimetrexate—Nausea—Pemetrexed—lung cancer	0.000411	0.00356	CcSEcCtD
Trimetrexate—Nausea—Gefitinib—lung cancer	0.000408	0.00354	CcSEcCtD
Trimetrexate—Thrombocytopenia—Topotecan—lung cancer	0.000406	0.00352	CcSEcCtD
Trimetrexate—Anaemia—Vinorelbine—lung cancer	0.000402	0.00348	CcSEcCtD
Trimetrexate—Thrombocytopenia—Erlotinib—lung cancer	0.000402	0.00348	CcSEcCtD
Trimetrexate—Asthenia—Teniposide—lung cancer	0.000402	0.00348	CcSEcCtD
Trimetrexate—Neutropenia—Etoposide—lung cancer	0.0004	0.00347	CcSEcCtD
Trimetrexate—Pruritus—Teniposide—lung cancer	0.000396	0.00343	CcSEcCtD
Trimetrexate—Neutropenia—Paclitaxel—lung cancer	0.000393	0.0034	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—TYMS—lung cancer	0.000392	0.00741	CbGpPWpGaD
Trimetrexate—Hypocalcaemia—Doxorubicin—lung cancer	0.000387	0.00335	CcSEcCtD
Trimetrexate—DHFR—lymph node—lung cancer	0.00038	0.0767	CbGeAlD
Trimetrexate—Blood bilirubin increased—Doxorubicin—lung cancer	0.000374	0.00324	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—ALB—lung cancer	0.000373	0.00705	CbGpPWpGaD
Trimetrexate—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.000371	0.00321	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—CREBBP—lung cancer	0.000368	0.00695	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—RB1—lung cancer	0.000366	0.00692	CbGpPWpGaD
Trimetrexate—Alanine aminotransferase increased—Docetaxel—lung cancer	0.000363	0.00315	CcSEcCtD
Trimetrexate—Fatigue—Topotecan—lung cancer	0.000358	0.0031	CcSEcCtD
Trimetrexate—Vomiting—Teniposide—lung cancer	0.000356	0.00308	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Doxorubicin—lung cancer	0.000354	0.00307	CcSEcCtD
Trimetrexate—Fatigue—Erlotinib—lung cancer	0.000354	0.00307	CcSEcCtD
Trimetrexate—Rash—Teniposide—lung cancer	0.000353	0.00306	CcSEcCtD
Trimetrexate—Dermatitis—Teniposide—lung cancer	0.000353	0.00306	CcSEcCtD
Trimetrexate—Feeling abnormal—Vinblastine—lung cancer	0.000352	0.00305	CcSEcCtD
Trimetrexate—Thrombocytopenia—Vinorelbine—lung cancer	0.000348	0.00301	CcSEcCtD
Trimetrexate—Feeling abnormal—Topotecan—lung cancer	0.000342	0.00296	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—TP53—lung cancer	0.000338	0.00639	CbGpPWpGaD
Trimetrexate—Neutropenia—Docetaxel—lung cancer	0.000333	0.00288	CcSEcCtD
Trimetrexate—Nausea—Teniposide—lung cancer	0.000333	0.00288	CcSEcCtD
Trimetrexate—Anaemia—Irinotecan—lung cancer	0.000332	0.00287	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—TYMS—lung cancer	0.00033	0.00624	CbGpPWpGaD
Trimetrexate—Body temperature increased—Topotecan—lung cancer	0.000328	0.00284	CcSEcCtD
Trimetrexate—Body temperature increased—Erlotinib—lung cancer	0.000325	0.00281	CcSEcCtD
Trimetrexate—Anaemia—Gemcitabine—lung cancer	0.000323	0.0028	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—CDKN2A—lung cancer	0.000322	0.00608	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RB1—lung cancer	0.000318	0.00601	CbGpPWpGaD
Trimetrexate—Asthenia—Vinblastine—lung cancer	0.000306	0.00266	CcSEcCtD
Trimetrexate—Fatigue—Vinorelbine—lung cancer	0.000306	0.00265	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL2—lung cancer	0.000302	0.00571	CbGpPWpGaD
Trimetrexate—Anaemia—Cisplatin—lung cancer	0.000301	0.00261	CcSEcCtD
Trimetrexate—Asthenia—Topotecan—lung cancer	0.000298	0.00258	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.000295	0.00256	CcSEcCtD
Trimetrexate—Confusional state—Irinotecan—lung cancer	0.000295	0.00256	CcSEcCtD
Trimetrexate—Asthenia—Erlotinib—lung cancer	0.000295	0.00255	CcSEcCtD
Trimetrexate—Pruritus—Topotecan—lung cancer	0.000294	0.00254	CcSEcCtD
Trimetrexate—Feeling abnormal—Vinorelbine—lung cancer	0.000293	0.00254	CcSEcCtD
Trimetrexate—Pruritus—Erlotinib—lung cancer	0.00029	0.00252	CcSEcCtD
Trimetrexate—Thrombocytopenia—Irinotecan—lung cancer	0.000287	0.00248	CcSEcCtD
Trimetrexate—Convulsion—Cisplatin—lung cancer	0.000282	0.00245	CcSEcCtD
Trimetrexate—Body temperature increased—Vinorelbine—lung cancer	0.000281	0.00243	CcSEcCtD
Trimetrexate—Thrombocytopenia—Gemcitabine—lung cancer	0.000279	0.00242	CcSEcCtD
Trimetrexate—Anaemia—Etoposide—lung cancer	0.000276	0.00239	CcSEcCtD
Trimetrexate—Vomiting—Vinblastine—lung cancer	0.000272	0.00235	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	0.000271	0.00513	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	0.00027	0.00511	CbGpPWpGaD
Trimetrexate—Anaemia—Paclitaxel—lung cancer	0.00027	0.00234	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—RB1—lung cancer	0.000266	0.00502	CbGpPWpGaD
Trimetrexate—Vomiting—Topotecan—lung cancer	0.000264	0.00229	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—CDKN1A—lung cancer	0.000263	0.00497	CbGpPWpGaD
Trimetrexate—Rash—Topotecan—lung cancer	0.000262	0.00227	CcSEcCtD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—lung cancer	0.000262	0.00494	CbGpPWpGaD
Trimetrexate—Dermatitis—Topotecan—lung cancer	0.000261	0.00227	CcSEcCtD
Trimetrexate—Vomiting—Erlotinib—lung cancer	0.000261	0.00226	CcSEcCtD
Trimetrexate—Thrombocytopenia—Cisplatin—lung cancer	0.00026	0.00226	CcSEcCtD
Trimetrexate—Rash—Erlotinib—lung cancer	0.000259	0.00224	CcSEcCtD
Trimetrexate—Dermatitis—Erlotinib—lung cancer	0.000259	0.00224	CcSEcCtD
Trimetrexate—Convulsion—Etoposide—lung cancer	0.000259	0.00224	CcSEcCtD
Trimetrexate—Hyponatraemia—Doxorubicin—lung cancer	0.000258	0.00224	CcSEcCtD
Trimetrexate—Asthenia—Vinorelbine—lung cancer	0.000255	0.00221	CcSEcCtD
Trimetrexate—Nausea—Vinblastine—lung cancer	0.000254	0.0022	CcSEcCtD
Trimetrexate—Convulsion—Paclitaxel—lung cancer	0.000253	0.0022	CcSEcCtD
Trimetrexate—Fatigue—Irinotecan—lung cancer	0.000252	0.00219	CcSEcCtD
Trimetrexate—Pruritus—Vinorelbine—lung cancer	0.000251	0.00218	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—EP300—lung cancer	0.00025	0.00473	CbGpPWpGaD
Trimetrexate—Nausea—Topotecan—lung cancer	0.000246	0.00214	CcSEcCtD
Trimetrexate—Fatigue—Gemcitabine—lung cancer	0.000246	0.00213	CcSEcCtD
Trimetrexate—Confusional state—Etoposide—lung cancer	0.000246	0.00213	CcSEcCtD
Trimetrexate—Nausea—Erlotinib—lung cancer	0.000244	0.00211	CcSEcCtD
Trimetrexate—Feeling abnormal—Irinotecan—lung cancer	0.000241	0.00209	CcSEcCtD
Trimetrexate—Confusional state—Paclitaxel—lung cancer	0.000241	0.00209	CcSEcCtD
Trimetrexate—Blood creatinine increased—Doxorubicin—lung cancer	0.000241	0.00209	CcSEcCtD
Trimetrexate—Neutropenia—Methotrexate—lung cancer	0.00024	0.00208	CcSEcCtD
Trimetrexate—Thrombocytopenia—Etoposide—lung cancer	0.000238	0.00207	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	0.000236	0.00447	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Gemcitabine—lung cancer	0.000235	0.00204	CcSEcCtD
Trimetrexate—Thrombocytopenia—Paclitaxel—lung cancer	0.000234	0.00203	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—FOXM1—lung cancer	0.000232	0.00439	CbGpPWpGaD
Trimetrexate—Body temperature increased—Irinotecan—lung cancer	0.000231	0.00201	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000231	0.00201	CcSEcCtD
Trimetrexate—Anaemia—Docetaxel—lung cancer	0.000229	0.00199	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	0.000229	0.00432	CbGpPWpGaD
Trimetrexate—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000227	0.00196	CcSEcCtD
Trimetrexate—Vomiting—Vinorelbine—lung cancer	0.000226	0.00196	CcSEcCtD
Trimetrexate—Body temperature increased—Gemcitabine—lung cancer	0.000225	0.00195	CcSEcCtD
Trimetrexate—DHFR—Metabolism—COL4A3BP—lung cancer	0.000224	0.00424	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AZIN2—lung cancer	0.000224	0.00424	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—RB1—lung cancer	0.000224	0.00423	CbGpPWpGaD
Trimetrexate—Rash—Vinorelbine—lung cancer	0.000224	0.00194	CcSEcCtD
Trimetrexate—Dermatitis—Vinorelbine—lung cancer	0.000224	0.00194	CcSEcCtD
Trimetrexate—Feeling abnormal—Cisplatin—lung cancer	0.000219	0.0019	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—MYC—lung cancer	0.000218	0.00412	CbGpPWpGaD
Trimetrexate—Convulsion—Docetaxel—lung cancer	0.000215	0.00186	CcSEcCtD
Trimetrexate—Nausea—Vinorelbine—lung cancer	0.000211	0.00183	CcSEcCtD
Trimetrexate—Body temperature increased—Cisplatin—lung cancer	0.00021	0.00182	CcSEcCtD
Trimetrexate—Asthenia—Irinotecan—lung cancer	0.00021	0.00182	CcSEcCtD
Trimetrexate—Fatigue—Etoposide—lung cancer	0.00021	0.00182	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—FOXM1—lung cancer	0.000208	0.00393	CbGpPWpGaD
Trimetrexate—Neutropenia—Doxorubicin—lung cancer	0.000208	0.0018	CcSEcCtD
Trimetrexate—Fatigue—Paclitaxel—lung cancer	0.000206	0.00178	CcSEcCtD
Trimetrexate—Asthenia—Gemcitabine—lung cancer	0.000205	0.00177	CcSEcCtD
Trimetrexate—Confusional state—Docetaxel—lung cancer	0.000204	0.00177	CcSEcCtD
Trimetrexate—Pruritus—Gemcitabine—lung cancer	0.000202	0.00175	CcSEcCtD
Trimetrexate—Feeling abnormal—Etoposide—lung cancer	0.000201	0.00174	CcSEcCtD
Trimetrexate—Thrombocytopenia—Docetaxel—lung cancer	0.000198	0.00172	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—lung cancer	0.000197	0.00372	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Paclitaxel—lung cancer	0.000197	0.00171	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—TP53—lung cancer	0.000194	0.00367	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—PPP2R1B—lung cancer	0.000193	0.00364	CbGpPWpGaD
Trimetrexate—Body temperature increased—Etoposide—lung cancer	0.000193	0.00167	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—CDKN1A—lung cancer	0.000191	0.00361	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ATP5H—lung cancer	0.000191	0.0036	CbGpPWpGaD
Trimetrexate—Asthenia—Cisplatin—lung cancer	0.000191	0.00165	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—lung cancer	0.00019	0.00358	CbGpPWpGaD
Trimetrexate—Body temperature increased—Paclitaxel—lung cancer	0.000189	0.00164	CcSEcCtD
Trimetrexate—Vomiting—Irinotecan—lung cancer	0.000186	0.00161	CcSEcCtD
Trimetrexate—Rash—Irinotecan—lung cancer	0.000185	0.0016	CcSEcCtD
Trimetrexate—Dermatitis—Irinotecan—lung cancer	0.000184	0.0016	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—LMNA—lung cancer	0.000184	0.00347	CbGpPWpGaD
Trimetrexate—Vomiting—Gemcitabine—lung cancer	0.000181	0.00157	CcSEcCtD
Trimetrexate—Rash—Gemcitabine—lung cancer	0.00018	0.00156	CcSEcCtD
Trimetrexate—Dermatitis—Gemcitabine—lung cancer	0.00018	0.00156	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL6—lung cancer	0.000178	0.00336	CbGpPWpGaD
Trimetrexate—Asthenia—Etoposide—lung cancer	0.000175	0.00151	CcSEcCtD
Trimetrexate—Fatigue—Docetaxel—lung cancer	0.000174	0.00151	CcSEcCtD
Trimetrexate—Nausea—Irinotecan—lung cancer	0.000174	0.00151	CcSEcCtD
Trimetrexate—Pruritus—Etoposide—lung cancer	0.000172	0.00149	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—PPP2R1B—lung cancer	0.000172	0.00325	CbGpPWpGaD
Trimetrexate—Asthenia—Paclitaxel—lung cancer	0.000171	0.00148	CcSEcCtD
Trimetrexate—DHFR—Metabolism—PLBD1—lung cancer	0.00017	0.00321	CbGpPWpGaD
Trimetrexate—Nausea—Gemcitabine—lung cancer	0.000169	0.00147	CcSEcCtD
Trimetrexate—Vomiting—Cisplatin—lung cancer	0.000169	0.00146	CcSEcCtD
Trimetrexate—Pruritus—Paclitaxel—lung cancer	0.000169	0.00146	CcSEcCtD
Trimetrexate—Rash—Cisplatin—lung cancer	0.000168	0.00145	CcSEcCtD
Trimetrexate—Dermatitis—Cisplatin—lung cancer	0.000167	0.00145	CcSEcCtD
Trimetrexate—Feeling abnormal—Docetaxel—lung cancer	0.000167	0.00145	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CCND1—lung cancer	0.000166	0.00314	CbGpPWpGaD
Trimetrexate—Anaemia—Methotrexate—lung cancer	0.000165	0.00143	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—LMNA—lung cancer	0.000164	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN1A—lung cancer	0.000161	0.00304	CbGpPWpGaD
Trimetrexate—Body temperature increased—Docetaxel—lung cancer	0.00016	0.00139	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—MYC—lung cancer	0.000158	0.00299	CbGpPWpGaD
Trimetrexate—Nausea—Cisplatin—lung cancer	0.000158	0.00137	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—lung cancer	0.000156	0.00294	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HSD17B10—lung cancer	0.000155	0.00294	CbGpPWpGaD
Trimetrexate—Convulsion—Methotrexate—lung cancer	0.000155	0.00134	CcSEcCtD
Trimetrexate—Vomiting—Etoposide—lung cancer	0.000155	0.00134	CcSEcCtD
Trimetrexate—DHFR—Disease—PGAM1—lung cancer	0.000154	0.00291	CbGpPWpGaD
Trimetrexate—Rash—Etoposide—lung cancer	0.000154	0.00133	CcSEcCtD
Trimetrexate—Dermatitis—Etoposide—lung cancer	0.000153	0.00133	CcSEcCtD
Trimetrexate—Vomiting—Paclitaxel—lung cancer	0.000152	0.00132	CcSEcCtD
Trimetrexate—Rash—Paclitaxel—lung cancer	0.000151	0.0013	CcSEcCtD
Trimetrexate—Dermatitis—Paclitaxel—lung cancer	0.00015	0.0013	CcSEcCtD
Trimetrexate—Confusional state—Methotrexate—lung cancer	0.000147	0.00127	CcSEcCtD
Trimetrexate—Asthenia—Docetaxel—lung cancer	0.000145	0.00126	CcSEcCtD
Trimetrexate—Nausea—Etoposide—lung cancer	0.000145	0.00125	CcSEcCtD
Trimetrexate—DHFR—Metabolism—CKB—lung cancer	0.000145	0.00273	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SDC4—lung cancer	0.000144	0.00271	CbGpPWpGaD
Trimetrexate—Pruritus—Docetaxel—lung cancer	0.000143	0.00124	CcSEcCtD
Trimetrexate—Anaemia—Doxorubicin—lung cancer	0.000143	0.00124	CcSEcCtD
Trimetrexate—Thrombocytopenia—Methotrexate—lung cancer	0.000143	0.00124	CcSEcCtD
Trimetrexate—Nausea—Paclitaxel—lung cancer	0.000142	0.00123	CcSEcCtD
Trimetrexate—DHFR—Metabolism—GSTM2—lung cancer	0.000136	0.00257	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CNDP2—lung cancer	0.000136	0.00257	CbGpPWpGaD
Trimetrexate—Convulsion—Doxorubicin—lung cancer	0.000134	0.00116	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—MYC—lung cancer	0.000133	0.00252	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTMR3—lung cancer	0.000132	0.0025	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PGAM1—lung cancer	0.000129	0.00243	CbGpPWpGaD
Trimetrexate—Vomiting—Docetaxel—lung cancer	0.000129	0.00112	CcSEcCtD
Trimetrexate—Rash—Docetaxel—lung cancer	0.000128	0.00111	CcSEcCtD
Trimetrexate—Dermatitis—Docetaxel—lung cancer	0.000127	0.0011	CcSEcCtD
Trimetrexate—Confusional state—Doxorubicin—lung cancer	0.000127	0.0011	CcSEcCtD
Trimetrexate—DHFR—Disease—SKI—lung cancer	0.000127	0.00239	CbGpPWpGaD
Trimetrexate—Fatigue—Methotrexate—lung cancer	0.000126	0.00109	CcSEcCtD
Trimetrexate—Thrombocytopenia—Doxorubicin—lung cancer	0.000124	0.00107	CcSEcCtD
Trimetrexate—DHFR—Disease—B4GALT5—lung cancer	0.000123	0.00232	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2A7—lung cancer	0.000123	0.00232	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—TYMS—lung cancer	0.000121	0.00229	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SDC4—lung cancer	0.00012	0.00227	CbGpPWpGaD
Trimetrexate—Nausea—Docetaxel—lung cancer	0.00012	0.00104	CcSEcCtD
Trimetrexate—Feeling abnormal—Methotrexate—lung cancer	0.00012	0.00104	CcSEcCtD
Trimetrexate—Body temperature increased—Methotrexate—lung cancer	0.000115	0.000999	CcSEcCtD
Trimetrexate—DHFR—Disease—PXN—lung cancer	0.00011	0.00208	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—RRM1—lung cancer	0.00011	0.00207	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA3—lung cancer	0.00011	0.00207	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—BIRC5—lung cancer	0.000109	0.00206	CbGpPWpGaD
Trimetrexate—Fatigue—Doxorubicin—lung cancer	0.000109	0.000944	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—TYMS—lung cancer	0.000108	0.00205	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKR1C1—lung cancer	0.000108	0.00204	CbGpPWpGaD
Trimetrexate—Asthenia—Methotrexate—lung cancer	0.000105	0.000907	CcSEcCtD
Trimetrexate—Feeling abnormal—Doxorubicin—lung cancer	0.000104	0.000902	CcSEcCtD
Trimetrexate—Pruritus—Methotrexate—lung cancer	0.000103	0.000894	CcSEcCtD
Trimetrexate—DHFR—Metabolism—B4GALT5—lung cancer	0.000103	0.00195	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA4—lung cancer	0.0001	0.00189	CbGpPWpGaD
Trimetrexate—Body temperature increased—Doxorubicin—lung cancer	9.98e-05	0.000865	CcSEcCtD
Trimetrexate—DHFR—Disease—NPPA—lung cancer	9.91e-05	0.00187	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA2—lung cancer	9.76e-05	0.00184	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—BIRC5—lung cancer	9.74e-05	0.00184	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PPIA—lung cancer	9.68e-05	0.00183	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ALDOA—lung cancer	9.6e-05	0.00181	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TERT—lung cancer	9.44e-05	0.00178	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA1—lung cancer	9.42e-05	0.00178	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCC3—lung cancer	9.32e-05	0.00176	CbGpPWpGaD
Trimetrexate—Vomiting—Methotrexate—lung cancer	9.27e-05	0.000804	CcSEcCtD
Trimetrexate—Rash—Methotrexate—lung cancer	9.2e-05	0.000797	CcSEcCtD
Trimetrexate—Dermatitis—Methotrexate—lung cancer	9.19e-05	0.000796	CcSEcCtD
Trimetrexate—DHFR—Disease—ADCY1—lung cancer	9.07e-05	0.00171	CbGpPWpGaD
Trimetrexate—Asthenia—Doxorubicin—lung cancer	9.06e-05	0.000785	CcSEcCtD
Trimetrexate—DHFR—Metabolism—AKR1C1—lung cancer	9.02e-05	0.0017	CbGpPWpGaD
Trimetrexate—Pruritus—Doxorubicin—lung cancer	8.94e-05	0.000774	CcSEcCtD
Trimetrexate—DHFR—Disease—ENO2—lung cancer	8.89e-05	0.00168	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SMARCA4—lung cancer	8.84e-05	0.00167	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PPP2R1B—lung cancer	8.84e-05	0.00167	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—UGT1A1—lung cancer	8.76e-05	0.00165	CbGpPWpGaD
Trimetrexate—Nausea—Methotrexate—lung cancer	8.66e-05	0.000751	CcSEcCtD
Trimetrexate—DHFR—Metabolism—GNG11—lung cancer	8.45e-05	0.0016	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—RB1—lung cancer	8.21e-05	0.00155	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ENO1—lung cancer	8.08e-05	0.00153	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALDOA—lung cancer	8.04e-05	0.00152	CbGpPWpGaD
Trimetrexate—Vomiting—Doxorubicin—lung cancer	8.03e-05	0.000696	CcSEcCtD
Trimetrexate—Rash—Doxorubicin—lung cancer	7.96e-05	0.00069	CcSEcCtD
Trimetrexate—Dermatitis—Doxorubicin—lung cancer	7.96e-05	0.00069	CcSEcCtD
Trimetrexate—DHFR—Metabolism—NCOA3—lung cancer	7.81e-05	0.00147	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCG2—lung cancer	7.59e-05	0.00143	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ADCY1—lung cancer	7.59e-05	0.00143	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APP—lung cancer	7.51e-05	0.00142	CbGpPWpGaD
Trimetrexate—Nausea—Doxorubicin—lung cancer	7.5e-05	0.00065	CcSEcCtD
Trimetrexate—DHFR—Disease—FGF9—lung cancer	7.45e-05	0.00141	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ENO2—lung cancer	7.45e-05	0.00141	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HPGDS—lung cancer	7.45e-05	0.00141	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PPP2R1B—lung cancer	7.4e-05	0.0014	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—RB1—lung cancer	7.34e-05	0.00139	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTT1—lung cancer	7.22e-05	0.00136	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—lung cancer	7.22e-05	0.00136	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GCLC—lung cancer	7.14e-05	0.00135	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2A6—lung cancer	7.14e-05	0.00135	CbGpPWpGaD
Trimetrexate—DHFR—Disease—JUNB—lung cancer	7.12e-05	0.00134	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ENO1—lung cancer	6.77e-05	0.00128	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN2A—lung cancer	6.46e-05	0.00122	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MDM2—lung cancer	6.26e-05	0.00118	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FOXO3—lung cancer	6.24e-05	0.00118	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CCND1—lung cancer	6.1e-05	0.00115	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2E1—lung cancer	6.07e-05	0.00115	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NQO1—lung cancer	6e-05	0.00113	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—lung cancer	5.9e-05	0.00112	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—EP300—lung cancer	5.62e-05	0.00106	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HES1—lung cancer	5.53e-05	0.00104	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CCND1—lung cancer	5.45e-05	0.00103	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—STK11—lung cancer	5.41e-05	0.00102	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN1A—lung cancer	5.28e-05	0.000997	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERCC2—lung cancer	5.17e-05	0.000976	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERBB3—lung cancer	5.05e-05	0.000954	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MAPK3—lung cancer	5.03e-05	0.000951	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—EP300—lung cancer	5.02e-05	0.000949	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTP1—lung cancer	5.01e-05	0.000946	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MYC—lung cancer	4.89e-05	0.000925	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CAT—lung cancer	4.87e-05	0.00092	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TERT—lung cancer	4.84e-05	0.000915	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCB1—lung cancer	4.74e-05	0.000895	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR1—lung cancer	4.7e-05	0.000888	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TYMS—lung cancer	4.65e-05	0.000879	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HIF1A—lung cancer	4.63e-05	0.000875	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTM1—lung cancer	4.6e-05	0.000869	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MAPK3—lung cancer	4.5e-05	0.00085	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOA1—lung cancer	4.47e-05	0.000844	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MYC—lung cancer	4.38e-05	0.000827	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP1A1—lung cancer	4.36e-05	0.000824	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ERCC2—lung cancer	4.33e-05	0.000817	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APC—lung cancer	4.08e-05	0.000771	CbGpPWpGaD
Trimetrexate—DHFR—Disease—KIT—lung cancer	4.08e-05	0.000771	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EGF—lung cancer	4.03e-05	0.000762	CbGpPWpGaD
Trimetrexate—DHFR—Disease—BRAF—lung cancer	3.83e-05	0.000724	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6R—lung cancer	3.79e-05	0.000716	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CREBBP—lung cancer	3.78e-05	0.000715	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOA1—lung cancer	3.74e-05	0.000707	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAP2K1—lung cancer	3.61e-05	0.000682	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TP53—lung cancer	3.59e-05	0.000679	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CD—lung cancer	3.59e-05	0.000678	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CG—lung cancer	3.42e-05	0.000645	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—POMC—lung cancer	3.25e-05	0.000614	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MDM2—lung cancer	3.21e-05	0.000607	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RAF1—lung cancer	3.2e-05	0.000605	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CREBBP—lung cancer	3.17e-05	0.000598	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERBB2—lung cancer	3.17e-05	0.000598	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTOR—lung cancer	3.13e-05	0.000591	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CB—lung cancer	3.13e-05	0.000591	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD4—lung cancer	3.12e-05	0.000589	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTGS2—lung cancer	3.1e-05	0.000585	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CD—lung cancer	3e-05	0.000567	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALB—lung cancer	2.96e-05	0.00056	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDKN1A—lung cancer	2.71e-05	0.000511	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTEN—lung cancer	2.7e-05	0.00051	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CB—lung cancer	2.62e-05	0.000495	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTGS2—lung cancer	2.59e-05	0.00049	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EP300—lung cancer	2.58e-05	0.000487	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SRC—lung cancer	2.5e-05	0.000473	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT3—lung cancer	2.42e-05	0.000456	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NRAS—lung cancer	2.41e-05	0.000455	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAPK3—lung cancer	2.31e-05	0.000436	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTEN—lung cancer	2.26e-05	0.000427	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MYC—lung cancer	2.24e-05	0.000424	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EGFR—lung cancer	2.2e-05	0.000415	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—EP300—lung cancer	2.16e-05	0.000408	CbGpPWpGaD
Trimetrexate—DHFR—Disease—KRAS—lung cancer	2.07e-05	0.000392	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CA—lung cancer	1.91e-05	0.00036	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HRAS—lung cancer	1.76e-05	0.000333	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6—lung cancer	1.69e-05	0.000319	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CA—lung cancer	1.6e-05	0.000301	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKT1—lung cancer	1.56e-05	0.000294	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AKT1—lung cancer	1.3e-05	0.000246	CbGpPWpGaD
